Patients in their early forties often arrive with a cluster of complaints that resist a tidy diagnosis: mid-afternoon fatigue, new central weight gain, sleep that fragments at 3 a.m., and cycles that are still regular enough to look reassuring on paper. The temptation is to treat each symptom on its own. The more useful question is whether insulin signalling has already begun to drift.1
Longitudinal cohort data suggest that the metabolic phase of the menopause transition precedes the endocrine phase by several years. That gap is the clinical opportunity, and it is routinely missed because standard panels stop at fasting glucose and A1c — both of which stay in range long after compensatory hyperinsulinemia begins.2
Why standard screening misses the window
Fasting glucose is a lagging indicator. By the time it rises, beta-cell compensation has already been running for years. In practice this means a patient can present with textbook insulin resistance physiology and a completely unremarkable metabolic panel.
What to add to the panel
- Fasting insulin, with HOMA-IR calculated rather than eyeballed
- Triglyceride-to-HDL ratio as an inexpensive surrogate
- Waist-to-height ratio, measured at every visit
- Optional: 2-hour insulin during a 75 g challenge for ambiguous cases
The metabolic phase of the transition precedes the endocrine phase — which is precisely why the standard panel reassures everyone for years longer than it should.— Kareem Kandil, ND
A staged assessment framework
Staging keeps the workup proportionate. Stage one is inexpensive and universal; stage two is reserved for patients whose surrogates are already abnormal.
| Stage | Tests | Act if |
|---|---|---|
| 1 — Screen | Fasting insulin, glucose, lipids, WHtR | HOMA-IR > 1.9 or WHtR > 0.50 |
| 2 — Characterize | 2-h OGTT with insulin, hs-CRP, ALT | 2-h insulin > 60 µIU/mL |
| 3 — Monitor | Repeat stage 1 at 12 weeks | < 10% change in HOMA-IR |
Interventions, ordered by observed effect
Across the reviewed trials the ordering was consistent, and it is not the ordering most patients expect. Resistance training led; supplement protocols were adjunctive rather than primary.3
- Resistance training, 2×/week. Largest single effect on fasting insulin.
- Protein redistribution. 30 g at breakfast reduced afternoon glycemic excursions.
- Sleep consolidation. Treating the 3 a.m. waking improved morning cortisol and insulin together.
- Targeted nutrients. Inositol and magnesium as support, not substitution.
Bringing it into the visit
The framework is designed to fit a standard follow-up rather than a dedicated metabolic consult: one added blood draw, one measurement, one exercise prescription, one scheduled recheck. Patients respond well to being told a window exists and that it is currently open.
